Traditionally, disease was defined based on symptom expression and treated using a one size fits all approach.

It is now recognized that many diseases are complex and heterogenous, comprising distinct molecular subtypes that are driven by discrete pathways.

Our team employs cutting-edge technologies that define disease endotypes on the basis of variations in the structure of biological networks, which function across multiple layers of regulation.